AIM
USNA icon

Aigen Investment Management’s Usana Health Sciences USNA Stock Holding History

Aigen Investment Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-202
Closed -$15K – 1082
2020
Q3 		$15K Sell
202
-4,615
-96% -$370K ﹤0.01% 796
2020
Q2 		$354K Buy
4,817
+3,821
+384% +$300K 0.05% 562
2020
Q1 		$58K Sell
996
-6,799
-87% -$473K 0.01% 956
2019
Q4 		$612K Buy
+7,795
New +$574K 0.1% 279

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aigen Investment Management's USNA Position: Q4 2020 in Review

Aigen Investment Management sold out of Usana Health Sciences (USNA) in Q4 2020, closing a stake of 202 shares — an estimated $15K sold.

Aigen Investment Management first reported a position in USNA in Q4 2019 and held it in 4 quarters. The position peaked at $612K in Q4 2019. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2020.

  • Aigen Investment Management reported no remaining Usana Health Sciences position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 202 Usana Health Sciences shares in Q4 2020, an estimated $15K.
  • Aigen Investment Management first reported a position in Usana Health Sciences in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Usana Health Sciences position peaked at $612K in Q4 2019.
  • 191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.